Clinical trial

COVID-19 Booster Vaccination in Persons With Multiple Sclerosis

NCT05081271

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2021-10-15

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2021-10-15Date precision: day

Registry last updated2022-11-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Homologous boosterBIOLOGICAL

Heterologous boosterBIOLOGICAL

Sponsors & collaborators

Griffin Hospitallead sponsor

Yale-Griffin Prevention Research Centercollaborator

Multiple Sclerosis Treatment Centercollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05081271 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.